Related Experiment Video

Updated: Apr 14, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

2.2K

Repressors of reprogramming

Melissa Popowski1, Haley Tucker1

  • 1Melissa Popowski, the Rockefeller University, New York, NY 10065, United States.

World Journal of Stem Cells
|April 28, 2015
PubMed

Insights

Developing safer and more efficient methods for creating induced pluripotent stem cells (iPSCs) is crucial. This review explores reprogramming barriers to advance regenerative medicine and disease modeling using iPSCs.

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Cellular Reprogramming

Background:

  • Induced pluripotent stem cells (iPSCs) offer promise for personalized regenerative medicine.
  • Current iPSC generation is inefficient and uses potentially oncogenic proteins.
  • Safer and more efficient reprogramming methods are needed for clinical applications.

Purpose of the Study:

  • To review less-focused areas of reprogramming, specifically barriers to the process.
  • To stimulate novel ideas for developing safer and more efficient iPSC generation methods.
  • To facilitate advancements in disease modeling and clinical applications of iPSCs.

Main Methods:

  • Literature review focusing on reprogramming barriers.
  • Analysis of challenges in inducing pluripotency in somatic cells.
  • Survey of existing and potential reprogramming strategies.

Main Results:

  • Identified key barriers hindering efficient and safe iPSC generation.
  • Highlighted the need for alternative reprogramming strategies beyond forced gene expression.
  • Emphasized the potential of understanding reprogramming hurdles for future research.

Conclusions:

  • Overcoming reprogramming barriers is essential for unlocking the full potential of iPSCs.
  • Improved iPSC generation will enhance disease modeling and regenerative therapies.
  • Further research into reprogramming challenges will lead to safer clinical applications.
Keywords:
Induced pluripotencyReprogrammingStem cells

More Related Videos

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

7.1K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.5K

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.5K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
9.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

3.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K